NeoGenomics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NeoGenomics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $0.05 | $0.01 | 400.0 % |
Mar 2024 | 2024-04-30 | $-0.02 | $-0.05 | 60.0 % |
Dec 2023 | 2024-02-20 | $0.03 | $-0.02 | 250.0 % |
Sep 2023 | 2023-11-06 | $0 | $-0.08 | 100.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $167.82M | $167.01M | 0.49 % |
Jun 2024 | 2024-07-29 | $164.50M | $161.85M | 1.64 % |
Mar 2024 | 2024-04-30 | $156.24M | $149.89M | 4.24 % |
Dec 2023 | 2024-02-20 | $155.55M | $152.54M | 1.98 % |
NeoGenomics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
NeoGenomics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $0.05, which beat the estimate of $0.01.
NeoGenomics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.